Medtronic plc (MDT)

NYSE: MDT · Real-Time Price · USD
94.22
+1.34 (1.44%)
At close: Sep 26, 2025, 4:00 PM EDT
94.49
+0.27 (0.29%)
After-hours: Sep 26, 2025, 7:56 PM EDT
1.44%
Market Cap 120.85B
Revenue (ttm) 34.20B
Net Income (ttm) 4.66B
Shares Out 1.28B
EPS (ttm) 3.62
PE Ratio 26.02
Forward PE 16.43
Dividend $2.84 (3.01%)
Ex-Dividend Date Sep 26, 2025
Volume 5,057,608
Open 93.85
Previous Close 92.88
Day's Range 93.48 - 94.73
52-Week Range 79.29 - 96.25
Beta 0.79
Analysts Buy
Price Target 102.62 (+8.92%)
Earnings Date Aug 19, 2025

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial Statements

Analyst Forecast

According to 15 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $102.62, which is an increase of 8.92% from the latest price.

Price Target
$102.62
(8.92% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Medtronic: FY26 Outlook Strengthened By New Product Launches

Medtronic (MDT) is undervalued, with strong organic growth and an 11% upside to a $105 target price, supporting a Buy rating. MDT's innovation pipeline, portfolio transformation, and spin-off of the d...

2 days ago - Seeking Alpha

Medtronic plc (MDT) Presents at Bank of America Global Healthcare Conference 2025 Transcript

Medtronic plc (NYSE:MDT) Bank of America Global Healthcare Conference 2025 September 24, 2025 9:10 AM EDT Company Participants Thierry Pieton - Executive VP & CFO Presentation Unknown Analyst We're g...

3 days ago - Seeking Alpha

Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland , Sept. 19, 2025 /PRNewswir...

8 days ago - PRNewsWire

Medtronic: Buy This Dividend Aristocrat While It's Good Value

Medtronic remains a Buy for long-term investors, offering steady growth, durable income, and an attractive valuation below historical averages. MDT delivered solid fiscal Q1 2026 results, with 8.4% re...

10 days ago - Seeking Alpha

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Other symbols: ABBVPINC
10 days ago - Benzinga

Medtronic Announces Pricing of €1.5 Billion of Senior Notes

GALWAY, Ireland , Sept. 15, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offe...

12 days ago - PRNewsWire

Medtronic initiates global pivotal study of cardiac pacing in a new patient population

Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserved ejection fraction (HFpEF) who have limited treatment options today GALW...

12 days ago - PRNewsWire

Medtronic Plc (MDT) Presents At Deutsche Bank Healthcare Summit Transcript

Medtronic plc (NYSE:MDT) Deutsche Bank Healthcare Summit September 10, 2025 12:00 PM EDT Company Participants Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Presen...

17 days ago - Seeking Alpha

Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Medtronic plc (NYSE:MDT) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Thierry Pieton - Executive VP & CFO Conference Call Participants Pa...

19 days ago - Seeking Alpha

Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)

Medtronic plc (NYSE:MDT) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive...

23 days ago - Seeking Alpha

Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. ,...

23 days ago - PRNewsWire

FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes

GALWAY, Ireland , Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones t...

25 days ago - PRNewsWire

Medtronic executives to speak at upcoming investor conferences

GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Well...

4 weeks ago - PRNewsWire

Why Medtronic Has Been Stuck for Over 1,100 Days And What Lies Ahead

Medtronic MDT has been trapped in a tight consolidation band for what feels like forever. For more than 1,100 days, the stock has stubbornly stayed between $75 and $95, showing little sign of life.

4 weeks ago - Benzinga

Best Dividend Aristocrats For September 2025

Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A...

4 weeks ago - Seeking Alpha

Medtronic makes two key additions to its board. How activist Elliott can build shareholder value

The stage seems to be set for a long-term mutually beneficial relationship between the parties.

5 weeks ago - CNBC

Medtronic: Earnings Are Solid, New Board Additions Add Intrigue

Medtronic delivered solid earnings, with standout growth in Cardiovascular, but overall performance remains mixed due to weaker Neuroscience and MedSurg segments. Elliott Management's activist involve...

5 weeks ago - Seeking Alpha

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

5 weeks ago - Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc MDT posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effect...

5 weeks ago - Benzinga

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Other symbols: BMYXRAY
5 weeks ago - Benzinga

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1.5% on Tuesday.

5 weeks ago - Benzinga

Activist investor Elliott push spurs changes at Medtronic

Medical device maker Medtronic is making changes to its board after Elliott Investment Management became one of its largest shareholders. CNBC's David Faber breaks down the details.

5 weeks ago - CNBC Television

Medtronic plc (MDT) Q1 2026 Earnings Call Transcript

Medtronic plc (NYSE:MDT) Q1 2026 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Geoffrey Straub Martha - Chairman of the Board & CEO Michael Marinaro - Executive VP & Presid...

5 weeks ago - Seeking Alpha

Medtronic Posts Earnings Beat and Elliott Buys Stake. The Stock Falls Anyway.

Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.

5 weeks ago - Barrons

Medtronic raises annual profit forecast on lower tariff impact

Medical-device maker Medtronic raised its fiscal 2026 profit forecast on Tuesday and said it expects a smaller-than-expected impact from the tariffs proposed by U.S. President Donald Trump.

5 weeks ago - Reuters